Ariadne Genomics, Inc., and Prolexys Pharmaceuticals, Inc. announce a collaboration to deliver superior pathway analysis tools to boost pharmaceutical research related to target identification and novel therapeutic discovery. The Human Interactome Database (HID) by Prolexys will be integrated with Ariadne’s PathwayStudio® and PathwayExpert™, and available for purchasing with its pathway analysis software.
